Evidence of drug-response heterogeneity rapidly generated from a single cancer cell

被引:9
|
作者
Wang, Rong [1 ]
Jin, Chengmeng [1 ]
Hu, Xun [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Canc Inst,Sch Med, Minist Educ Peoples Republ China,Key Lab Canc Pre, Hangzhou, Zhejiang, Peoples R China
关键词
heterogeneity; cancer; drug-response; STOCHASTIC GENE-EXPRESSION; INTRATUMOR HETEROGENEITY; INDUCED APOPTOSIS; LACTIC-ACIDOSIS; RESISTANCE; EVOLUTION; VARIABILITY; GLYCOLYSIS; ISSUE; LUNG;
D O I
10.18632/oncotarget.17064
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One cancer cell line is believed to be composed of numerous clones with different drug sensitivity. We sought to investigate the difference of drug-response pattern in clones from a cell line or from a single cell. We showed that 22 clones derived from 4T1 cells were drastically different from each other with respect to drug-response pattern against 11 anticancer drugs and expression profile of 19 genes associated with drug resistance or sensitivity. Similar results were obtained using daughter clones derived from a single 4T1 cell. Each daughter clone showed distinct drug-response pattern and gene expression profile. Similar results were also obtained using Bcap37 cells. We conclude that a single cancer cell can rapidly produce a population of cells with high heterogeneity of drug response and the acquisition of drug-response heterogeneity is random.
引用
收藏
页码:41113 / 41124
页数:12
相关论文
共 50 条
  • [31] Breast Cancer Stem Cell Heterogeneity and Drug Resistance
    Liu, Suling
    CANCER SCIENCE, 2021, 112 : 994 - 994
  • [32] Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
    Gauert, Anton
    Olk, Nadine
    Pimentel-Gutierrez, Helia
    Astrahantseff, Kathy
    Jensen, Lasse D.
    Cao, Yihai
    Eggert, Angelika
    Eckert, Cornelia
    Hagemann, Anja I. H.
    CANCERS, 2020, 12 (07) : 1 - 13
  • [33] Characterization of intratumoral heterogeneity in drug sensitivity and non-cell autonomous mechanisms of drug resistance using subclonal cell populations derived from a single breast cancer cell line
    Friend, Chandler M.
    Brugge, Joan S.
    Kuiken, Hendrik J.
    Corsello, Steven M.
    Mader, Christopher C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [34] Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
    Schmidt, Felix
    Efferth, Thomas
    PHARMACEUTICALS, 2016, 9 (02)
  • [35] Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
    Martin, Steve Z.
    Wagner, Daniel C.
    Hoerner, Nina
    Horst, David
    Lang, Hauke
    Tagscherer, Katrin E.
    Roth, Wilfried
    BMC CANCER, 2019, 19 (01)
  • [36] Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
    Steve Z. Martin
    Daniel C. Wagner
    Nina Hörner
    David Horst
    Hauke Lang
    Katrin E. Tagscherer
    Wilfried Roth
    BMC Cancer, 19
  • [37] Identification of novel drug-response determinants for 5-FU and CDDP in esophageal squamous cell carcinoma (ESCC)
    Fumoto, Shoichi
    Tanimoto, Keiji
    Otani, Keiko
    Ohtaki, Megu
    Noguchi, Tsuyoshi
    Hiyama, Eiso
    Eguchi, Hidetaka
    Narahara, Hiroyuki
    Nishiyama, Masahiko
    Hiyama, Keiko
    CANCER RESEARCH, 2009, 69
  • [38] Quantifying heterogeneity to drug response in cancer-stroma kinetics
    Alemanno, Francesco
    Cavo, Marta
    Delle Cave, Donatella
    Fachechi, Alberto
    Rizzo, Riccardo
    D'Amone, Eliana
    Gigli, Giuseppe
    Lonardo, Enza
    Barra, Adriano
    del Mercato, Loretta L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (11)
  • [39] Tumoral Heterogeneity of A Single Gastric Cancer Cell Line
    Imanishi, Daiki
    Kawabata, Kyoka
    Nishikubo, Hinano
    Tsukada, Yuki
    Ma, Dongheng
    Yamamoto, Yurie
    Fan, Canfeng
    Sakuma, Takashi
    Maruo, Koji
    Yashiro, Masakazu
    Maeda, Kiyoshi
    CANCER SCIENCE, 2025, 116 : 276 - 276
  • [40] SPONGE-GEL SUPPORTED HISTOCULTURE DRUG-RESPONSE ASSAY FOR HEAD AND NECK-CANCER - CORRELATIONS WITH CLINICAL-RESPONSE TO CISPLATIN
    ROBBINS, KT
    CONNORS, KM
    STORNIOLO, AM
    HANCHETT, C
    HOFFMAN, RM
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1994, 120 (03) : 288 - 292